Release Date: 12/05/10 15:40 Summary: EBB Income Fund Litigation Update Price Sensitive: No Download Document 28.03KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%